Timing of immune checkpoint inhibitor infusion predicts survival in advanced esophageal squamous cell carcinoma: A retrospective cohort study
Wenjing Wang, Chengyuan Fan, Li Shen, Ruijie Ni, Lisha Ye, Weimin Mao, Wei Hong, Xiaoling Xu · 2026
Read Timing of immune checkpoint inhibitor infusion predicts survival in advanced esophageal squamous cell carcinoma: A retrospective cohort study by Wenjing Wang, Chengyuan Fan, Li Shen, Ruijie Ni, Lisha Ye, Weimin Mao, Wei Hong, Xiaoling Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13477538.txt.
Description
BackgroundEsophageal squamous cell carcinoma (ESCC) is a highly lethal malignancy for which immune checkpoint inhibitors (ICIs) have improved outcomes, yet significant inter-patient variability in response persists. Emerging evidence suggests that circadian rhythms modulate anti-tumor immunity, but the impact of ICI infusion timing on ESCC prognosis remains unexplored.
Catalog record
| CREATOR | Wenjing Wang, Chengyuan Fan, Li Shen, Ruijie Ni, Lisha Ye, Weimin Mao, Wei Hong, Xiaoling Xu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |